The benefit of digoxin was driven by reduced risk of new-onset or worsening HF hospitalizations, just like its benefit in HFrEF.

The consistent underrepresentation of African populations in clinical studies is a ‘crisis of scientific validity,’ Bamba ...

The lack of effect on different measures of coronary plaque reinforce the need for a large CV outcomes trial in these ...

The controversial findings had interventional cardiologists looking for answers, with operator experience coming into focus.

Hypertension’s burden has continued to rise around the world, with disparities between lower- versus higher-income countries ...

Proven to prevent preeclampsia, aspirin needs to be better embedded in routine prenatal practice, researchers say.

For femoropopliteal and BTK patients, the sirolimus balloon was associated with fewer limb events at 1 year than POBA.

A culturally tailored meal plan featuring traditional foods, as well as other support, reduced hospital stays within 90 days.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

News from ACC 2026 dominates our most-read list, along with the dyslipidemia guidelines, Lp(a) vs CAC, and apixaban for VTE.

How has the pharmacotherapy for STEMI changed over the past 46 years? Ginger Jiang and C. Michael Gibson discuss treating patients with zalunfiban at first medical contact.